The Nx Gen Sequencing Familial Hemiplegic Migraine Test is a cutting-edge diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with Familial Hemiplegic Migraine (FHM). FHM is a rare subtype of migraine with aura, characterized by temporary weakness on one side of the body, in addition to the typical migraine symptoms. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.
Utilizing Next-Generation Sequencing (NGS) technology, this test comprehensively analyzes the genes known to be linked with FHM, including CACNA1A, ATP1A2, and SCN1A. NGS allows for the simultaneous sequencing of millions of DNA fragments, ensuring a highly sensitive and accurate identification of genetic variations that could predispose individuals to FHM.
The test is priced at 4680 AED and is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. By opting for this test, individuals with a family history of FHM can gain valuable insights into their genetic predisposition to the condition. This information can be crucial for early diagnosis, personalized treatment plans, and preventive strategies, ultimately enhancing the quality of life for those affected by or at risk of familial hemiplegic migraine.
The Nx Gen Sequencing 4H Syndrome Test, available at DNA Labs UAE, is a cutting-edge genetic testing procedure designed to identify the presence of 4H Syndrome, also known as Hypomyelination with Hypogonadotropic Hypogonadism and Hypodontia. This comprehensive test leverages Next Generation Sequencing (NGS) technology, offering a highly sensitive and specific analysis of the genetic mutations associated with this rare, inherited condition. By examining the patient's DNA sample, the test can pinpoint specific genetic alterations, providing crucial information for diagnosis, management, and treatment planning. The cost of the Nx Gen Sequencing 4H Syndrome Test is 4680 AED, reflecting the advanced technology and expertise required to perform this sophisticated analysis. Conducted at DNA Labs UAE, this test represents a significant step forward in the field of genetic diagnostics, enabling patients and their families to gain a deeper understanding of 4H Syndrome and how it affects their lives.
The ZNF783 gene prostate cancer genetic test is a specialized diagnostic tool designed to identify specific genetic mutations associated with an increased risk of developing prostate cancer. This test focuses on the ZNF783 gene, which has been implicated in the development and progression of prostate cancer through various genetic studies. By analyzing this gene, the test can help in assessing an individual's genetic predisposition to prostate cancer, enabling early detection and intervention strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, this test provides a comprehensive evaluation of the ZNF783 gene's status. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then meticulously analyzed in the laboratory to detect any genetic abnormalities or mutations associated with prostate cancer risk.
The cost of the ZNF783 gene prostate cancer genetic test is 4400 AED. While the price may seem significant, the value of the information it provides can be invaluable for individuals with a family history of prostate cancer or those deemed at high risk due to other factors. Early detection of genetic predisposition allows for proactive measures, including more frequent screenings, lifestyle adjustments, and in some cases, preventative treatments, thereby potentially reducing the impact of prostate cancer on an individual's life.
Overall, the ZNF783 gene prostate cancer genetic test at DNA Labs UAE represents a critical step forward in personalized medicine, offering individuals insight into their genetic risk and empowering them with the information needed to make informed health decisions.
The HOXB13 gene is known for its significant role in the development of familial prostate cancer. A mutation in this gene has been linked to an increased risk of developing prostate cancer, especially among families with a history of the disease. Recognizing the importance of early detection and intervention, DNA Labs UAE offers a specialized genetic test to identify mutations in the HOXB13 gene. This test is crucial for individuals with a family history of prostate cancer, as it can provide valuable insights into their risk of developing the condition.
The test is conducted with a sample of the individual's DNA, typically collected through a simple and non-invasive process. The analysis focuses on identifying any alterations in the HOXB13 gene that are associated with an increased risk of prostate cancer. By detecting these mutations early, individuals can take proactive steps in monitoring and managing their health, potentially leading to earlier intervention and better outcomes.
The cost of the HOXB13 gene test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated for those at risk. Early detection and preventive measures can not only save lives but also reduce the emotional and financial burden of advanced cancer treatment. Individuals considering this test are encouraged to consult with their healthcare provider to understand how the results may impact their health management plan.
The RNASEL Gene Prostate Cancer Hereditary Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the RNASEL gene, which are associated with an increased risk of developing prostate cancer. This gene plays a critical role in the body's ability to control cell growth and apoptosis, making its proper function crucial in preventing cancerous developments. Mutations in the RNASEL gene have been linked specifically to hereditary prostate cancer type 1, a condition that is passed down through families and significantly elevates the risk of prostate cancer in men.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab to detect any genetic abnormalities in the RNASEL gene. This test is particularly recommended for men with a family history of prostate cancer, as it can provide crucial information about their risk and guide in making informed decisions regarding monitoring and prevention strategies.
The cost of the RNASEL Gene Prostate Cancer Hereditary Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. While the price may seem high, the value of the information it provides can be invaluable for those at risk, offering a chance for early intervention and potentially life-saving measures.
The ELAC2 gene, associated with Hereditary Prostate Cancer Type 2, plays a significant role in understanding the genetic predisposition to prostate cancer. This gene, when mutated, increases the risk of developing prostate cancer, marking its importance in genetic testing for individuals with a family history of the condition. DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the ELAC2 gene, providing valuable insights into an individual's susceptibility to hereditary prostate cancer type 2.
This test is crucial for early detection and preventive measures, offering a proactive approach to managing the risk of prostate cancer. Priced at 4400 AED, the test is conducted with precision and confidentiality, ensuring individuals receive comprehensive support and information regarding their genetic health. By understanding one's genetic predisposition through the ELAC2 gene test, individuals can make informed decisions about their health, potentially leading to early intervention and tailored treatment strategies.
The "HNF1A Gene Renal Cell Carcinoma Due to HNF1A Germline Mutation Genetic Test" is a specialized diagnostic procedure aimed at identifying germline mutations in the HNF1A gene, which have been linked to an increased risk of developing renal cell carcinoma. This test is particularly important for individuals with a family history of renal cell carcinoma or those who have been identified as having an increased risk of this type of cancer due to genetic predispositions. By analyzing a sample of the patient's DNA, this test can detect specific mutations in the HNF1A gene that are known to contribute to the development of renal cell carcinoma, enabling early detection and intervention strategies.
The test is offered at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of HNF1A gene mutations. Undergoing this test at DNA Labs UAE provides patients with the opportunity to take proactive steps in managing their health, potentially leading to early diagnosis and more effective treatment options for renal cell carcinoma.
The "MET Gene Renal Cell Carcinoma Papillary Type 1 Familial Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MET gene, which are closely associated with the development of Papillary Type 1 Renal Cell Carcinoma (RCC). This type of cancer affects the kidneys and is characterized by the growth of small, finger-like projections in the tumor. The familial aspect of this test indicates its importance for individuals with a family history of RCC, as identifying mutations in the MET gene can provide crucial information for early detection, risk assessment, and personalized treatment strategies for family members.
The test is conducted using a sample of the patient's blood or tissue, where DNA is extracted and analyzed for specific mutations in the MET gene that are known to contribute to the development of this cancer type. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the specialized technology required to accurately identify these genetic markers.
By opting for this genetic test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic predisposition to Papillary Type 1 RCC, enabling them to make informed decisions about their health management and potentially reducing the risk of developing this type of cancer through early intervention and monitoring.
The RET Gene RET Selective Sequencing of Exons 5, 8, 10, 11, and 13-16 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations within specific exons of the RET gene that are commonly associated with various hereditary cancer syndromes, including Multiple Endocrine Neoplasia type 2 (MEN2) and Medullary Thyroid Carcinoma (MTC). By focusing on exons 5, 8, 10, 11, and 13-16, this test aims to provide a targeted approach in the genetic evaluation of individuals at risk for these conditions, facilitating early detection and the implementation of preventive or therapeutic measures. The test is priced at 4400 AED, reflecting the intricate process of selective exon sequencing and the comprehensive analysis required to ensure accurate results. Conducted at the state-of-the-art facilities of DNA Labs UAE, patients can expect a reliable service grounded in scientific expertise and cutting-edge genetic technology.
The CYLD gene Spiegler-Brooke Syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CYLD gene, which are linked to the development of Spiegler-Brooke Syndrome. This rare condition is characterized by the growth of multiple benign skin tumors that typically appear in adolescence or early adulthood. These tumors can vary in size and are often found on the scalp, face, and trunk. The syndrome can also lead to tumors in other parts of the body, including internal organs.
The test is performed by collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the CYLD gene. Identifying these mutations can confirm a diagnosis of Spiegler-Brooke Syndrome, which is crucial for managing the condition and planning appropriate treatment. Early diagnosis can help in monitoring and potentially removing tumors before they cause discomfort or lead to complications.
This genetic test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, which reflects the comprehensive analysis and expertise required to accurately identify mutations in the CYLD gene. By opting for this test at DNA Labs UAE, patients can expect reliable results, professional counseling, and guidance on the implications of the test outcomes for their health and management of the syndrome.
